López-Riverol O, Camacho-Limas CP, Gerson-Cwilich R

Language: Spanish
References: 20
Page: 31-40
PDF size: 158.62 Kb.

ABSTRACT

ABSTRACT Clinical manifestations unrelated to local invasion or compression by a malignancy, are described extensively in the literature as paraneoplastic syndromes and may affect all systems of the human body, its pathophysiology is related to abnormal production of biologically active substances or reaction cross between healthy tissue and tumor tissue, neoplasms most often associated with the development of this entity is small cell lung cancer and breast cancer. Early diagnosis and treatment based on the oncological control of the primary tumor improves the quality of life and may prolong survival of patients. The objective is describe current concepts narratively in diagnosis and treatment of this entity.

REFERENCES

1. Pelosof LC, Gerber DE. Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment. Mayo Clin Proc 2010; 85(9): 838-54.

2. Dalmau J, Rosenfeld M. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7(4): 327-340.

3. Tormoehlen LM, Pascuzzi RM. Thymoma, Myasthenia gravis, and other paraneoplastic sindromes. Hematol Oncol Clin North Am 2008; 22(3): 509-26.

4. Graber JJ, Nolan CP. Myelopathies in patients with cancer. Arch Neurol 2010; 67(3); 298-304.

5. Naveed S, Okoli K, Hollingsworth J, Kasmani R. Guillain- Barre syndrome as a paraneoplastic manifestation of smallcell carcinoma of lung. South Med J 2010; 103(2): 156-8.

6. Colantuoni M, Matano E, Alfieri S, De Placido S, Carlomagno C. Guillain-Barre Syndrome Associated with Gastric Cancer: Paraneoplastic Syndrome or Immunological Disorder? World J Oncol 2010; 1(6): 247-9.

7. Freeman R. Autonomic Peripheral Neuropathy. Neurol Clin 2007; 25(1): 277-301.

8. Dourmishev L, Amato AA. Paraneoplastic dermatological manifestation of gastrointestinal malignancies. World J Gastroenterol 2009; 15(35): 4372-9.

9. Briemberg HR, Amato AA. Neuromuscular complications of cancer. Neurol Clin 2003; 21(1): 141-65.

10. Forga L, Anda E, Martinez de Esteban JP. Síndromes hormonales paraneoplásicos. An Sist Sanit Navar 2005; 28(2): 213-26.

11. Kaltsas G, Androulakis II, de Herder WW, Grssmann AB. Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer 2010; 17(3): R173-R193.

12. Stewart AF. Hypercalcemia associated with cancer. N Engl J Med 2005; 352(4): 373-9.

13. Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial Evaluation of the patient with lung cancer. Tests, and paraneoplastic syndromes cancer: symptoms, signs, laboratory initial. Chest 2003; 123/1 Suppl.): 97S-104S.

14. Shahani S, Nudelman RJ, Nalini R, Kin HS, Sanson SL. Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature. Diagn Pathol 2010; 31(5): 56.

15. Govindan R, Stinchcombe TE, Morgensztern D. Paraneoplastic syndrome in De Vita, Hellman and Rosemberg’s, Cancer Principles and Practice of Oncology. 10th edition, Wolters Kluwer Lippincott / Williams & Wilkins 2015; pp. 1894-904.

16. Santacroce L. Balducci L. (Updated 2009 November 19). Malignant Carcinoid Syndrome. eMedicine. Disponible en: http://emedicine.medscape.com/article/282515-overview

17. Pipkin CA, Lio PA. Cutaneous Manifestations of internal malignancies: An overview. Dermatol Clin 2008; 26(1): 1-15.

18. Thiers HB, Sahn RE, Callen JP. Cutaneous Manifestations of Internal Malignancy. CA Cancer J Clin 2009; 59(2): 73-98.

19. Manger B, Schett S. Paraneoplasic Syndromes in Rheumatology. Nat Rev Rheumatol 2014; 10(11); 662-70.

20. Zupancic M, Annamalai A, Brenneman J, Ranatunga S. Migratory Polyarthritis as a paraneoplastic syndrome. J Gen Intern Med 2008; 23(12): 2136-9.